Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy

Three Japanese adolescents with chronic hepatitis C were treated by direct‐acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Ken, Yamazaki, Yuichi, Kanayama, Yuki, Uehara, Daisuke, Tojima, Hiroki, Suga, Takayoshi, Kakizaki, Satoru, Sohara, Naondo, Horiguchi, Norio, Uraoka, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980949/
https://www.ncbi.nlm.nih.gov/pubmed/35414915
http://dx.doi.org/10.1002/ccr3.5690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980949/
https://www.ncbi.nlm.nih.gov/pubmed/35414915
http://dx.doi.org/10.1002/ccr3.5690

Ejemplares similares